Description
Izba (travoprost ophthalmic solution) 0.003% is a prescription eye drop used to decrease intraocular pressure in patients with open-angle glaucoma or high ocular pressure.
Fact Table
|
Formula
|
C26H35F3O6
|
License
|
US DailyMed, EU EMA
|
Bioavailability
|
3-6%
|
Legal status
|
Rx-Only
|
Chemical Name
|
Travoprost ophthalmic
|
Elimination half-life
|
1.5 hours (in aqueous fluid)
45 minutes (terminal)
|
Dosage (Strength)
|
0.003% Ophthalmic Solution
|
Pregnancy
|
Consult doctor
|
Brands
|
Izba
|
Protein binding
|
80%
|
PubChem CID
|
5282226
|
MedlinePlus
|
a602027
|
ChEBI
|
746859
|
ATC code
|
S01EE04
|
DrugBank
|
DB00287
|
KEGG
|
D01964
|
Routes of administration
|
Topical eye drops
|
Directions
Use Izba (travoprost) eye drops as directed by your doctor. Notify your doctor or pharmacist of any questions or concerns you have about the medication.
Recommended dosing: Place one drop into the affected eye(s) one time a day. Using Izba in the evening has shown optimal effect. If a dose is missed, continue treatment with the next planned dose.
Ingredients
Travoprost is the active ingredient contained in Izba eye drops. Inactive ingredients include a preservative (polyquaternium-1), boric acid, and propylene glycol.
Contraindications
Patients with an allergy to travoprost or to any of the other ingredients should not use Izba.
Patients who are pregnant or suspect that they are pregnant should also avoid using Izba.
Cautions
- Before you start using Izba eye drops, discuss the following with your doctor:
- All the prescription and over-the-counter medications you use, including other eye drops.
- Your allergies.
- Your health problems and medical history.
- If you are pregnant or breastfeeding.
- Patients should take out their contact lenses before placing Izba eye drops. They may reinsert the contact lenses 15 minutes after using Izba.
- Blurred vision and other visual disturbances may occur with the use of Izba. Do not drive or operate machinery until your vision clears.
- A gradual-and potentially permanent-change in eye color may occur with Izba use.
- Eyelids may become darkened with the use of Izba.
- Eyelashes may become longer, thicker, and more pigmented with the use of Izba. The number of eyelashes may also increase.
- Patients with iritis or uveitis should use Izba with caution.
- Macular edema can occur with the use of Izba.
- Bacterial eye infections can occur when using multiple-dose containers of eye drops. Patients should avoid touching the tip of the container to any surface to avoid contamination.
- Izba should not be administered to pediatric patients younger than 18 years of age.
Side Effects
Eye inflammation, itching, irritation, or dryness can occur with the use of Izba; however, these are not all the side effects that can occur. If you develop bothersome or persistent side effects, contact your doctor right away.
Reference:
Izba (travoprost ophthalmic solution). Dorval, Quebec: Novartis Pharmaceuticals Canada Inc.; 2021.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 13804